India to consider clinical trials data of two full doses of AstraZeneca vaccine
Thursday, 26 November 2020 India will consider clinical trial data for the two full-dose Oxford-AstraZenecaCovid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which is claimed to be up to 90% effective but has attracted criticism for dosing errors.
AstraZeneca, 3rd Major COVID-19 Vaccine, Shown to Be Effective and Cheaper.
On Monday, the drugmaker announced the "exciting results" based on an analysis of trials in the U.K. and Brazil.
Because the vaccine can be stored at fridge temperatures, it can be distributed around the world using the...
Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said on Monday. Ciara Lee reports
Monica Calazans, a 54-year-old nurse in Sao Paulo, became on Sunday the first person to be inoculated in Brazil, receiving the Chinese vaccine known as CoronaVac after Brazilian health regulator Anvisa approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca.
Vaccines minister Nadhim Zahawi has suggested that a gradual easing oflockdown restrictions will not begin before early March. He told BBCBreakfast: “If we take the mid-February target, two weeks after that you getyour protection, pretty much, for the Pfizer/BioNTech, three weeks for theOxford/AstraZeneca, you are protected. “One of the things we don’t know yet,and the deputy chief medical officer Jonathan Van-Tam is on record as saying‘look give me a couple of months and I’ll tell you’, is the impact of thevaccine on transmission rates ie on infecting people. “So there are a numberof caveats that stand in the way of us reopening the economy. “It will begradually, it will be probably through the tiered system but you’re looking atthat sort of period, two to three weeks after the middle of February, afterwe’ve protected the top four cohorts.”
Credit: PA - Press Association STUDIO Duration: 00:53Published
After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on Friday issued a release giving information on approving Covishield developed by AstraZeneca and Oxford University, which will be manufactured by Serum Institute of India (SII) in India. Drug regulating authority has also specified Serum Institute of India for importers provided with low cost in purchasing and delivery of vaccine to public. Approving the vaccine for conditional purpose, the department has also asked manufacturers or importers to get approval for registration in order to bring the vaccines. Nepal imposed nationwide and partial lockdown for most of 2020 with rise in imported cases which later took the form of local transmission spreading mostly in urban areas and major cities. The nationwide lockdown which started in March 2020 hampered daily life of people as well as businesses. They now expect to thrive with the approval of vaccine. Though the detailed inoculation plan of Nepal Government is yet to be disclosed, a total of 3 companies applied for approval to take steps forward with Serum Institute for import of vaccines. India has already made conditional emergency approval for Covishield manufactured by the Serum Institute. Being one of the largest producers of vaccines at low cost, India has promised to provide vaccine to its neighbours in near future.
The preparations are underway for the 13th edition of Aero India 2021' at Yelahanka Airforce Station. The event will be the first global airshow organised in the COVID era. It offers unique platform to International aviation sector to boost business. Aero India 2021' will be held from Feb 03- Feb 05, 2021
U.S. stocks started the week on an upswing after another drug company posted positive clinical trial results for a COVID-19 vaccine and reports surfaced that President-Elect Joe Biden plans to nominate..